Work

Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma.

Year: 1993

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.1993.11.10.1969

Authors: J A Sparano, R I Fisher, M Sunderland, K Margolin, M L Ernest, M Sznol, M B Atkins, J P Dutcher, K C Micetich, G R Weiss

Institutions: Albert Einstein College of Medicine, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center, Yeshiva University

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1105070095, G1505869703, CLINICAL TRIALS OF ACTIVATED HUMAN LEUKOCYTES, G2197280113, CLINICAL TRIALS OF ACTIVATED HUMAN LEUKOCYTES, CLINICAL TRIALS OF ACTIVATED HUMAN LEUKOCYTES

OpenAlex ID: W1925498946

FWCI: 2.674

Cites:

Cited by: 176

Related to: 10